20.06
price up icon4.05%   0.79
 
loading
前日終値:
$19.27
開ける:
$19.37
24時間の取引高:
148.51K
Relative Volume:
0.65
時価総額:
$494.11M
収益:
-
当期純損益:
$11.77M
株価収益率:
-129.67
EPS:
-0.1547
ネットキャッシュフロー:
$-19.23M
1週間 パフォーマンス:
+14.05%
1か月 パフォーマンス:
+43.62%
6か月 パフォーマンス:
-53.58%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$18.98
$20.34
1週間の範囲:
Value
$17.17
$20.34
52週間の値動き範囲:
Value
$12.06
$48.31

Tourmaline Bio Inc Stock (TRML) Company Profile

Name
名前
Tourmaline Bio Inc
Name
セクター
Healthcare (1201)
Name
電話
646-481-9832
Name
住所
27 WEST 24TH STREET, NEW YORK
Name
職員
58
Name
Twitter
Name
次回の収益日
2024-08-12
Name
最新のSEC提出書
Name
TRML's Discussions on Twitter

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-12-15 開始されました Jefferies Buy
2023-12-04 再開されました H.C. Wainwright Buy
2023-11-17 開始されました Truist Buy
2023-10-31 開始されました Guggenheim Buy
2023-10-25 開始されました Piper Sandler Overweight
2022-10-20 開始されました H.C. Wainwright Buy
2022-07-05 ダウングレード Morgan Stanley Overweight → Equal-Weight
すべてを表示

Tourmaline Bio Inc (TRML) 最新ニュース

pulisher
Sep 15, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $61.80 Average PT from Brokerages - MarketBeat

Sep 15, 2024
pulisher
Sep 15, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Recommendation of “Buy” from Analysts - Defense World

Sep 15, 2024
pulisher
Sep 12, 2024

Tourmaline Bio amends bylaws, updates proxy rules - Investing.com

Sep 12, 2024
pulisher
Sep 11, 2024

The Attractiveness of Investing In Tourmaline Bio Inc (TRML) is Growing - Knox Daily

Sep 11, 2024
pulisher
Sep 11, 2024

Tourmaline Bio amends bylaws, updates proxy rules - Investing.com India

Sep 11, 2024
pulisher
Sep 05, 2024

Tourmaline Bio Showcases Promising Candidate in Updated Presentation - TipRanks

Sep 05, 2024
pulisher
Sep 04, 2024

Tourmaline Oil Corp. (TSE:TOU) Senior Officer Mike Rose Purchases 2,500 Shares of Stock - Defense World

Sep 04, 2024
pulisher
Sep 03, 2024

Tourmaline Bio to Present at Upcoming Investor Conferences - StockTitan

Sep 03, 2024
pulisher
Sep 02, 2024

Investing in Tourmaline Bio Inc (TRML) Is Getting More Attractive - Knox Daily

Sep 02, 2024
pulisher
Sep 02, 2024

A Tale of Resilience: Tourmaline Bio Inc Amid Stock Market Turbulence - The InvestChronicle

Sep 02, 2024
pulisher
Aug 24, 2024

Tourmaline Bio CEO buys $26.4k of company stock - Investing.com India

Aug 24, 2024
pulisher
Aug 22, 2024

Tourmaline Bio CEO buys $26.4k of company stock - Investing.com

Aug 22, 2024
pulisher
Aug 22, 2024

Tourmaline Bio CEO buys $26.4k of company stock By Investing.com - Investing.com UK

Aug 22, 2024
pulisher
Aug 22, 2024

Tourmaline Bio (NASDAQ:TRML) versus Turnstone Biologics (NASDAQ:TSBX) Head-To-Head Review - Defense World

Aug 22, 2024
pulisher
Aug 21, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) CEO Sandeep Chidambar Kulkarni Purchases 5,221 Shares of Stock - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

INFINI RES FPO [I88] (ASX:I88) Insider Charles Armstrong Acquires 150,000 Shares of Stock - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

SG Americas Securities LLC Purchases Shares of 33,666 Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

4,526 Shares in Innovator Growth-100 Power Buffer ETF – July (BATS:NJUL) Bought by Brookstone Capital Management - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $61.80 Consensus Target Price from Brokerages - MarketBeat

Aug 21, 2024
pulisher
Aug 21, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

Judges Scientific (LON:JDG) PT Raised to £124 at Berenberg Bank - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

Tourmaline Bio CEO buys $71,997 in company stock - Investing.com India

Aug 21, 2024
pulisher
Aug 20, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) CEO Sandeep Chidambar Kulkarni Purchases 5,221 Shares - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

Tourmaline Bio CEO buys $71,997 in company stock - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Tourmaline Bio CEO buys $71,997 in company stock By Investing.com - Investing.com UK

Aug 20, 2024
pulisher
Aug 19, 2024

California State Teachers Retirement System Invests $334,000 in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Aug 19, 2024
pulisher
Aug 15, 2024

Q3 2024 EPS Estimates for Tourmaline Bio, Inc. (NASDAQ:TRML) Reduced by Analyst - MarketBeat

Aug 15, 2024
pulisher
Aug 15, 2024

HC Wainwright Analysts Reduce Earnings Estimates for Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Aug 15, 2024
pulisher
Aug 12, 2024

Tourmaline Bio's (TRML) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

Tourmaline Bio (NASDAQ:TRML) Receives Buy Rating from HC Wainwright - Defense World

Aug 12, 2024
pulisher
Aug 12, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Acquired by Vanguard Group Inc. - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

Vanguard Group Inc. Has $20.94 Million Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Aug 12, 2024
pulisher
Aug 10, 2024

Tourmaline Bio (NASDAQ:TRML) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Aug 10, 2024
pulisher
Aug 10, 2024

Tourmaline Bio (NASDAQ:TRML) Issues Quarterly Earnings Results - Defense World

Aug 10, 2024
pulisher
Aug 08, 2024

Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock - Yahoo Finance

Aug 08, 2024
pulisher
Aug 08, 2024

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Yahoo Finance

Aug 08, 2024
pulisher
Aug 08, 2024

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - ForexTV.com

Aug 08, 2024
pulisher
Aug 08, 2024

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - The Bakersfield Californian

Aug 08, 2024
pulisher
Aug 08, 2024

Janus Henderson Group PLC Invests $266,000 in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Aug 08, 2024
pulisher
Aug 08, 2024

Concurrent Technologies (LON:CNC) Shares Pass Above Two Hundred Day Moving Average of $97.15 - Defense World

Aug 08, 2024
pulisher
Aug 08, 2024

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - StockTitan

Aug 08, 2024
pulisher
Aug 05, 2024

Tourmaline Bio publishes design of Phase II clinical trial for TOUR006 - Yahoo Finance

Aug 05, 2024
pulisher
Aug 02, 2024

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024 - Yahoo Finance

Aug 02, 2024
pulisher
Aug 02, 2024

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024 - ForexTV.com

Aug 02, 2024
pulisher
Aug 02, 2024

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024 - StockTitan

Aug 02, 2024
pulisher
Jul 29, 2024

BNP Paribas Financial Markets Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Jul 29, 2024
pulisher
Jul 27, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Sees Significant Increase in Short Interest - MarketBeat

Jul 27, 2024
pulisher
Jul 27, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Jul 27, 2024
pulisher
Jul 25, 2024

Swiss National Bank Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Jul 25, 2024
pulisher
Jul 25, 2024

Swiss National Bank Purchases Shares of 32,000 Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Jul 25, 2024
pulisher
Jul 24, 2024

A Guide To The Risks Of Investing In Tourmaline Bio Inc (TRML) - Knox Daily

Jul 24, 2024

Tourmaline Bio Inc (TRML) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Tourmaline Bio Inc (TRML) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Kulkarni Sandeep Chidambar
CEO
Aug 16 '24
Buy
13.79
5,221
71,998
5,221
MCDADE MARK
Director
Jan 29 '24
Buy
32.50
100,000
3,250,000
448,431
Kulkarni Sandeep Chidambar
CEO
Nov 17 '23
Buy
16.99
4,000
67,960
729,735
Thiara Parvinder
Director
Nov 17 '23
Buy
17.31
1,000
17,310
83,782
Castelein Caley
Director
Oct 27 '23
Buy
14.55
15,800
229,890
516,519
Castelein Caley
Director
Oct 25 '23
Buy
12.07
4,200
50,694
500,719
Kulkarni Sandeep Chidambar
CEO
Oct 26 '23
Buy
12.25
5,000
61,250
725,735
Kulkarni Sandeep Chidambar
CEO
Oct 24 '23
Buy
10.68
4,650
49,662
720,735
KANTOFF AARON
Director
Oct 24 '23
Buy
11.86
7,500
88,950
45,391
Thiara Parvinder
Director
Oct 24 '23
Buy
10.66
5,000
53,300
80,782
$26.55
price down icon 1.28%
$196.11
price down icon 1.22%
$28.98
price down icon 9.71%
$69.58
price up icon 1.94%
$127.27
price up icon 3.16%
$538.98
price up icon 0.25%
大文字化:     |  ボリューム (24 時間):